The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Personalized Medicine Market Research Report 2025

Global Personalized Medicine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1718515

No of Pages : 92

Ask Your Query

Synopsis

Individualized medication, medication "vary from person to person" , give full consideration to each patient's genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking Others drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.

The global Personalized Medicine market was valued at US$ 259380 million in 2023 and is anticipated to reach US$ 540120 million by 2030, witnessing a CAGR of 10.9% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Personalized Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicine.

Report Scope

The Personalized Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Personalized Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Personalized Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Abbott Laboratories
  • Agilent Technologies
  • Amgen
  • Astellas Pharma
  • Astrazeneca
  • Bayer AG
  • Celgene Corporation
  • Glaxosmithkline Plc
  • Illumina
  • Johnson & Johnson
  • Laboratory Corporation
  • Merck
  • Novartis AG
  • Roche Holding AG
  • Siemens AG
  • Takeda Pharmaceutical Company Limited

Segment by Type

  • Personalized Medicine Diagnostics
  • Personalized Medical Care
  • Personalized Medicine Therapeutics
  • Personalized Nutrition and Wellness

Segment by Application

  • Oncology
  • Central Nervous System (CNS)
  • Immunology
  • Respiratory
  • Others Applications

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Personalized Medicine Diagnostics
1.2.3 Personalized Medical Care
1.2.4 Personalized Medicine Therapeutics
1.2.5 Personalized Nutrition and Wellness
1.3 Market by Application
1.3.1 Global Personalized Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Central Nervous System (CNS)
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others Applications
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicine Market Perspective (2019-2030)
2.2 Personalized Medicine Growth Trends by Region
2.2.1 Global Personalized Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Personalized Medicine Historic Market Size by Region (2019-2024)
2.2.3 Personalized Medicine Forecasted Market Size by Region (2025-2030)
2.3 Personalized Medicine Market Dynamics
2.3.1 Personalized Medicine Industry Trends
2.3.2 Personalized Medicine Market Drivers
2.3.3 Personalized Medicine Market Challenges
2.3.4 Personalized Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicine Players by Revenue
3.1.1 Global Top Personalized Medicine Players by Revenue (2019-2024)
3.1.2 Global Personalized Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicine Revenue
3.4 Global Personalized Medicine Market Concentration Ratio
3.4.1 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine Revenue in 2023
3.5 Personalized Medicine Key Players Head office and Area Served
3.6 Key Players Personalized Medicine Product Solution and Service
3.7 Date of Enter into Personalized Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine Breakdown Data by Type
4.1 Global Personalized Medicine Historic Market Size by Type (2019-2024)
4.2 Global Personalized Medicine Forecasted Market Size by Type (2025-2030)
5 Personalized Medicine Breakdown Data by Application
5.1 Global Personalized Medicine Historic Market Size by Application (2019-2024)
5.2 Global Personalized Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Personalized Medicine Market Size (2019-2030)
6.2 North America Personalized Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Personalized Medicine Market Size by Country (2019-2024)
6.4 North America Personalized Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Medicine Market Size (2019-2030)
7.2 Europe Personalized Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Personalized Medicine Market Size by Country (2019-2024)
7.4 Europe Personalized Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicine Market Size (2019-2030)
8.2 Asia-Pacific Personalized Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Personalized Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Personalized Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Medicine Market Size (2019-2030)
9.2 Latin America Personalized Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Personalized Medicine Market Size by Country (2019-2024)
9.4 Latin America Personalized Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicine Market Size (2019-2030)
10.2 Middle East & Africa Personalized Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Personalized Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Personalized Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Personalized Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Personalized Medicine Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Personalized Medicine Introduction
11.2.4 Agilent Technologies Revenue in Personalized Medicine Business (2019-2024)
11.2.5 Agilent Technologies Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Personalized Medicine Introduction
11.3.4 Amgen Revenue in Personalized Medicine Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Detail
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Personalized Medicine Introduction
11.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2019-2024)
11.4.5 Astellas Pharma Recent Development
11.5 Astrazeneca
11.5.1 Astrazeneca Company Detail
11.5.2 Astrazeneca Business Overview
11.5.3 Astrazeneca Personalized Medicine Introduction
11.5.4 Astrazeneca Revenue in Personalized Medicine Business (2019-2024)
11.5.5 Astrazeneca Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Detail
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Personalized Medicine Introduction
11.6.4 Bayer AG Revenue in Personalized Medicine Business (2019-2024)
11.6.5 Bayer AG Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Detail
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Personalized Medicine Introduction
11.7.4 Celgene Corporation Revenue in Personalized Medicine Business (2019-2024)
11.7.5 Celgene Corporation Recent Development
11.8 Glaxosmithkline Plc
11.8.1 Glaxosmithkline Plc Company Detail
11.8.2 Glaxosmithkline Plc Business Overview
11.8.3 Glaxosmithkline Plc Personalized Medicine Introduction
11.8.4 Glaxosmithkline Plc Revenue in Personalized Medicine Business (2019-2024)
11.8.5 Glaxosmithkline Plc Recent Development
11.9 Illumina
11.9.1 Illumina Company Detail
11.9.2 Illumina Business Overview
11.9.3 Illumina Personalized Medicine Introduction
11.9.4 Illumina Revenue in Personalized Medicine Business (2019-2024)
11.9.5 Illumina Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Personalized Medicine Introduction
11.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2019-2024)
11.10.5 Johnson & Johnson Recent Development
11.11 Laboratory Corporation
11.11.1 Laboratory Corporation Company Detail
11.11.2 Laboratory Corporation Business Overview
11.11.3 Laboratory Corporation Personalized Medicine Introduction
11.11.4 Laboratory Corporation Revenue in Personalized Medicine Business (2019-2024)
11.11.5 Laboratory Corporation Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Personalized Medicine Introduction
11.12.4 Merck Revenue in Personalized Medicine Business (2019-2024)
11.12.5 Merck Recent Development
11.13 Novartis AG
11.13.1 Novartis AG Company Detail
11.13.2 Novartis AG Business Overview
11.13.3 Novartis AG Personalized Medicine Introduction
11.13.4 Novartis AG Revenue in Personalized Medicine Business (2019-2024)
11.13.5 Novartis AG Recent Development
11.14 Roche Holding AG
11.14.1 Roche Holding AG Company Detail
11.14.2 Roche Holding AG Business Overview
11.14.3 Roche Holding AG Personalized Medicine Introduction
11.14.4 Roche Holding AG Revenue in Personalized Medicine Business (2019-2024)
11.14.5 Roche Holding AG Recent Development
11.15 Siemens AG
11.15.1 Siemens AG Company Detail
11.15.2 Siemens AG Business Overview
11.15.3 Siemens AG Personalized Medicine Introduction
11.15.4 Siemens AG Revenue in Personalized Medicine Business (2019-2024)
11.15.5 Siemens AG Recent Development
11.16 Takeda Pharmaceutical Company Limited
11.16.1 Takeda Pharmaceutical Company Limited Company Detail
11.16.2 Takeda Pharmaceutical Company Limited Business Overview
11.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Introduction
11.16.4 Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2019-2024)
11.16.5 Takeda Pharmaceutical Company Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Personalized Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Personalized Medicine Diagnostics
Table 3. Key Players of Personalized Medical Care
Table 4. Key Players of Personalized Medicine Therapeutics
Table 5. Key Players of Personalized Nutrition and Wellness
Table 6. Global Personalized Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Personalized Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Personalized Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Personalized Medicine Market Share by Region (2019-2024)
Table 10. Global Personalized Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Personalized Medicine Market Share by Region (2025-2030)
Table 12. Personalized Medicine Market Trends
Table 13. Personalized Medicine Market Drivers
Table 14. Personalized Medicine Market Challenges
Table 15. Personalized Medicine Market Restraints
Table 16. Global Personalized Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Personalized Medicine Market Share by Players (2019-2024)
Table 18. Global Top Personalized Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine as of 2023)
Table 19. Ranking of Global Top Personalized Medicine Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Personalized Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Personalized Medicine Product Solution and Service
Table 23. Date of Enter into Personalized Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Personalized Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Personalized Medicine Revenue Market Share by Type (2019-2024)
Table 27. Global Personalized Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Personalized Medicine Revenue Market Share by Type (2025-2030)
Table 29. Global Personalized Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Personalized Medicine Revenue Market Share by Application (2019-2024)
Table 31. Global Personalized Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Personalized Medicine Revenue Market Share by Application (2025-2030)
Table 33. North America Personalized Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Personalized Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Personalized Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Personalized Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Personalized Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Personalized Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Personalized Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Personalized Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Personalized Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Personalized Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Personalized Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Personalized Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Personalized Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Personalized Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Personalized Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Personalized Medicine Product
Table 51. Abbott Laboratories Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Agilent Technologies Company Detail
Table 54. Agilent Technologies Business Overview
Table 55. Agilent Technologies Personalized Medicine Product
Table 56. Agilent Technologies Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 57. Agilent Technologies Recent Development
Table 58. Amgen Company Detail
Table 59. Amgen Business Overview
Table 60. Amgen Personalized Medicine Product
Table 61. Amgen Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 62. Amgen Recent Development
Table 63. Astellas Pharma Company Detail
Table 64. Astellas Pharma Business Overview
Table 65. Astellas Pharma Personalized Medicine Product
Table 66. Astellas Pharma Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 67. Astellas Pharma Recent Development
Table 68. Astrazeneca Company Detail
Table 69. Astrazeneca Business Overview
Table 70. Astrazeneca Personalized Medicine Product
Table 71. Astrazeneca Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 72. Astrazeneca Recent Development
Table 73. Bayer AG Company Detail
Table 74. Bayer AG Business Overview
Table 75. Bayer AG Personalized Medicine Product
Table 76. Bayer AG Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 77. Bayer AG Recent Development
Table 78. Celgene Corporation Company Detail
Table 79. Celgene Corporation Business Overview
Table 80. Celgene Corporation Personalized Medicine Product
Table 81. Celgene Corporation Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 82. Celgene Corporation Recent Development
Table 83. Glaxosmithkline Plc Company Detail
Table 84. Glaxosmithkline Plc Business Overview
Table 85. Glaxosmithkline Plc Personalized Medicine Product
Table 86. Glaxosmithkline Plc Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 87. Glaxosmithkline Plc Recent Development
Table 88. Illumina Company Detail
Table 89. Illumina Business Overview
Table 90. Illumina Personalized Medicine Product
Table 91. Illumina Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 92. Illumina Recent Development
Table 93. Johnson & Johnson Company Detail
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Personalized Medicine Product
Table 96. Johnson & Johnson Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 97. Johnson & Johnson Recent Development
Table 98. Laboratory Corporation Company Detail
Table 99. Laboratory Corporation Business Overview
Table 100. Laboratory Corporation Personalized Medicine Product
Table 101. Laboratory Corporation Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 102. Laboratory Corporation Recent Development
Table 103. Merck Company Detail
Table 104. Merck Business Overview
Table 105. Merck Personalized Medicine Product
Table 106. Merck Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 107. Merck Recent Development
Table 108. Novartis AG Company Detail
Table 109. Novartis AG Business Overview
Table 110. Novartis AG Personalized Medicine Product
Table 111. Novartis AG Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 112. Novartis AG Recent Development
Table 113. Roche Holding AG Company Detail
Table 114. Roche Holding AG Business Overview
Table 115. Roche Holding AG Personalized Medicine Product
Table 116. Roche Holding AG Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 117. Roche Holding AG Recent Development
Table 118. Siemens AG Company Detail
Table 119. Siemens AG Business Overview
Table 120. Siemens AG Personalized Medicine Product
Table 121. Siemens AG Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 122. Siemens AG Recent Development
Table 123. Takeda Pharmaceutical Company Limited Company Detail
Table 124. Takeda Pharmaceutical Company Limited Business Overview
Table 125. Takeda Pharmaceutical Company Limited Personalized Medicine Product
Table 126. Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2019-2024) & (US$ Million)
Table 127. Takeda Pharmaceutical Company Limited Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Personalized Medicine Market Share by Type: 2023 VS 2030
Figure 3. Personalized Medicine Diagnostics Features
Figure 4. Personalized Medical Care Features
Figure 5. Personalized Medicine Therapeutics Features
Figure 6. Personalized Nutrition and Wellness Features
Figure 7. Global Personalized Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Personalized Medicine Market Share by Application: 2023 VS 2030
Figure 9. Oncology Case Studies
Figure 10. Central Nervous System (CNS) Case Studies
Figure 11. Immunology Case Studies
Figure 12. Respiratory Case Studies
Figure 13. Others Applications Case Studies
Figure 14. Personalized Medicine Report Years Considered
Figure 15. Global Personalized Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Personalized Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Personalized Medicine Market Share by Region: 2023 VS 2030
Figure 18. Global Personalized Medicine Market Share by Players in 2023
Figure 19. Global Top Personalized Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Personalized Medicine Revenue in 2023
Figure 21. North America Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Personalized Medicine Market Share by Country (2019-2030)
Figure 23. United States Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Personalized Medicine Market Share by Country (2019-2030)
Figure 27. Germany Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Personalized Medicine Market Share by Region (2019-2030)
Figure 35. China Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Personalized Medicine Market Share by Country (2019-2030)
Figure 43. Mexico Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Personalized Medicine Market Share by Country (2019-2030)
Figure 47. Turkey Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Personalized Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 50. Agilent Technologies Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 51. Amgen Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 52. Astellas Pharma Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 53. Astrazeneca Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 54. Bayer AG Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 55. Celgene Corporation Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 56. Glaxosmithkline Plc Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 57. Illumina Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 58. Johnson & Johnson Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 59. Laboratory Corporation Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 60. Merck Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 61. Novartis AG Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 62. Roche Holding AG Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 63. Siemens AG Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 64. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Personalized Medicine Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock